Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Synthetic analogues of opioid growth factor linked to derivatives of glucosamine as a potential compounds for targeted therapy against pancreatic tumour

2019/35/B/NZ7/04212

Keywords:

analogues of opioid growth factor derivatives of glucosamine pancretic cancer cells animal model of pancreatic cancer cytotoxicity proliferation TCIPA

Descriptors:

  • NZ7_014:

Panel:

NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution :

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

woj. pomorskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

prof. Iwona Maria Inkielewicz-Stępniak 

Number of co-investigators in the project: 12

Call: OPUS 18 - announced on 2019-09-16

Amount awarded: 2 262 360 PLN

Project start date (Y-m-d): 2020-07-29

Project end date (Y-m-d): 2025-07-28

Project duration:: 60 months (the same as in the proposal)

Project status: Project completed

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

  • Publication in academic press/journals (2)
  1. Muramyl dipeptide-based analogs as potential anticancer compounds: Strategies to improve selectivity, biocompatibility, and efficiency
    Authors:
    Iwicka E., Hajtuch J., Dzierzbicka K., Inkielewicz-Stepniak I.
    Academic press:
    Front. Oncol. (rok: 2022, tom: 12, strony: 45671), Wydawca: FRONTIERS
    Status:
    Accepted for publication
    DOI:
    10.3389/fonc.2022.970967 - link to the publication
  2. Muramyl dipeptide-based analogs as potential anticancer compounds: Strategies to improve selectivity, biocompatibility, and efficiency
    Authors:
    Iwicka E., Hajtuch J., Dzierzbicka K., Inkielewicz-Stepniak I.
    Academic press:
    Front. Oncol. (rok: 2022, tom: 12, strony: 45671), Wydawca: FRONTIERS
    Status:
    Published
    DOI:
    10.3389/fonc.2022.970967 - link to the publication

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy